Previous 10 | Next 10 |
SEATTLE, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announces that ...
Physician-Scientist Dr. Steven Quay Provides Best-Selling Book, "Stay Safe: A Physician's Guide to Survive Coronavirus," to the White House Upon the News of COVID in the First Family According to Dr. Quay, MD, PhD, "the book provides lifesaving tips you can't find anywhere else ...
SEATTLE, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announce...
Atossa Therapeutics ( ATOS +14.7% ) has announced a positive interim safety assessment from the second cohort of 8 healthy participants in Phase 1 study of AT-301 administered by nasal spray, for the treatment of COVID-19. More news on: Atossa Therapeutics, Inc., Healthcare stocks news...
SEATTLE, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announce...
Sorrento Therapeutics (NASDAQ: SRNE ) +30% on FDA nod for early-stage COVID-19 antibody trial. More news on: Sorrento Therapeutics, Inc., Hepion Pharmaceuticals, Inc., Vaccinex, Inc., , Stocks on the move, Read more ...
SEATTLE , Sept. 14, 2020 /PRNewswire/ -- Renowned physician-scientist Dr. Steven Quay's , MD, PhD, CEO of Atossa Therapeutics, Inc. (NASDAQ: ATOS) new book " Stay Safe: A Physician's Guide to Survive Coronavirus ," is officially number one on five Amazon New Release Bestseller lists...
SEATTLE , Sept. 8, 2020 /PRNewswire/ -- Renowned physician-scientist Dr. Steven Quay , MD, PhD, CEO of Atossa Therapeutics, Inc. (NASDAQ: ATOS) is offering a simple tip for making your cloth Covid-19 face mask more effective. The technique is one of countless safety tips and i...
SEATTLE, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announce...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...